A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
NCT05139836
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
634
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Sponsor
AbbVie